Contec Medical Systems Co.,Ltd (SHE:300869)
China · Delayed Price · Currency is CNY 15.63
-0.20 (-1.26%)
Jan 20, 2026, 3:04 PM CST
SHE:300869 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -78.41 | -77.9 | 165.77 | 196.2 | 352.35 | 613.4 | Upgrade |
Depreciation & Amortization | 27.95 | 27.95 | 27.52 | 20.59 | 17.86 | 15.17 | Upgrade |
Other Amortization | 0.02 | 0.02 | - | - | - | 0.86 | Upgrade |
Loss (Gain) From Sale of Assets | 0.09 | 0.09 | 0.07 | 0.26 | 0.04 | 0 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 0.01 | 10.72 | 3.76 | Upgrade |
Loss (Gain) From Sale of Investments | -24.11 | -24.11 | -13.49 | -54.6 | -1.58 | -0.17 | Upgrade |
Provision & Write-off of Bad Debts | 1.44 | 1.44 | -1.03 | 2.02 | 0.38 | 1.04 | Upgrade |
Other Operating Activities | 90.54 | 105.63 | 32.7 | -40.98 | -115.35 | -0.42 | Upgrade |
Change in Accounts Receivable | -13.88 | -13.88 | 148.68 | -64.49 | -23.01 | -56.23 | Upgrade |
Change in Inventory | 74.03 | 74.03 | -85.05 | -17.39 | -144.98 | -167.96 | Upgrade |
Change in Accounts Payable | -33.09 | -33.09 | -78.3 | 59.34 | -93.11 | 189.72 | Upgrade |
Operating Cash Flow | 46.75 | 62.34 | 181.01 | 103.66 | 4.65 | 597.73 | Upgrade |
Operating Cash Flow Growth | 21.48% | -65.56% | 74.63% | 2130.42% | -99.22% | 1090.27% | Upgrade |
Capital Expenditures | -50.09 | -54.46 | -30.74 | -81.45 | -106.31 | -88.67 | Upgrade |
Sale of Property, Plant & Equipment | 0.62 | 0.95 | 0.11 | 0.25 | 0.12 | 0.01 | Upgrade |
Investment in Securities | -418.97 | 99.76 | -750 | -50 | 50 | -230 | Upgrade |
Other Investing Activities | -11.34 | -151.92 | 57.67 | 17.37 | 5.09 | 3.81 | Upgrade |
Investing Cash Flow | -479.79 | -105.68 | -722.96 | -113.82 | -51.09 | -314.85 | Upgrade |
Short-Term Debt Issued | - | 90 | 632.88 | 874.88 | 915.2 | 262.84 | Upgrade |
Long-Term Debt Issued | - | - | - | 690.1 | - | - | Upgrade |
Total Debt Issued | 227 | 90 | 632.88 | 1,565 | 915.2 | 262.84 | Upgrade |
Short-Term Debt Repaid | - | - | -1.06 | -787.05 | -312.1 | -18.53 | Upgrade |
Long-Term Debt Repaid | - | -379.21 | -1,191 | -1.87 | -0.35 | - | Upgrade |
Total Debt Repaid | -122.21 | -379.21 | -1,192 | -788.92 | -312.45 | -18.53 | Upgrade |
Net Debt Issued (Repaid) | 104.79 | -289.21 | -559.54 | 776.06 | 602.75 | 244.31 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 416.56 | Upgrade |
Common Dividends Paid | -110.29 | -127.72 | -68.7 | -123.92 | -102.31 | -1.86 | Upgrade |
Other Financing Activities | 695.17 | 673.18 | 244.79 | 129.2 | -666.06 | -280.41 | Upgrade |
Financing Cash Flow | 689.68 | 256.26 | -383.44 | 781.34 | -165.62 | 378.6 | Upgrade |
Foreign Exchange Rate Adjustments | 2.64 | 4.16 | 5.28 | 17.58 | -2.5 | -10.79 | Upgrade |
Net Cash Flow | 259.29 | 217.08 | -920.1 | 788.75 | -214.56 | 650.69 | Upgrade |
Free Cash Flow | -3.34 | 7.88 | 150.28 | 22.21 | -101.66 | 509.06 | Upgrade |
Free Cash Flow Growth | - | -94.75% | 576.62% | - | - | 1089.76% | Upgrade |
Free Cash Flow Margin | -0.68% | 1.64% | 20.12% | 3.12% | -11.19% | 36.33% | Upgrade |
Free Cash Flow Per Share | -0.01 | 0.02 | 0.36 | 0.05 | -0.25 | 1.36 | Upgrade |
Cash Income Tax Paid | 19.86 | 40.69 | 34.94 | 9.9 | 60.8 | -31.58 | Upgrade |
Levered Free Cash Flow | 4.9 | -449.78 | 70.11 | -46.16 | -97.74 | 281.44 | Upgrade |
Unlevered Free Cash Flow | 26.96 | -427.71 | 98.3 | -34.24 | -95.95 | 282.95 | Upgrade |
Change in Working Capital | 29.23 | 29.23 | -30.52 | -19.85 | -259.78 | -35.91 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.